| __timestamp | Bio-Techne Corporation | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 31073000 |
| Thursday, January 1, 2015 | 119401000 | 43216000 |
| Friday, January 1, 2016 | 140879000 | 50679000 |
| Sunday, January 1, 2017 | 199243000 | 79171000 |
| Monday, January 1, 2018 | 240636000 | 168218000 |
| Tuesday, January 1, 2019 | 264359000 | 210796000 |
| Wednesday, January 1, 2020 | 260583000 | 203613000 |
| Friday, January 1, 2021 | 324951000 | 234273000 |
| Saturday, January 1, 2022 | 372766000 | 265784000 |
| Sunday, January 1, 2023 | 378378000 | 344501000 |
| Monday, January 1, 2024 | 396826000 |
Unlocking the unknown
In the ever-evolving biotech industry, operational efficiency is key. Over the past decade, Bio-Techne Corporation and Insmed Incorporated have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Bio-Techne's SG&A expenses have surged by over 550% from 2014 to 2023, reflecting its aggressive expansion and market penetration strategies. In contrast, Insmed's SG&A expenses have grown by approximately 1,000% during the same period, indicating its rapid scaling and investment in operational infrastructure.
Bio-Techne consistently outpaced Insmed in SG&A spending, peaking at nearly 400 million in 2024. However, Insmed's expenses showed a significant leap in 2023, closing the gap with Bio-Techne. This trend suggests a strategic shift in Insmed's operational focus. Notably, data for Insmed in 2024 is missing, leaving room for speculation on its future trajectory.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Insmed Incorporated
SG&A Efficiency Analysis: Comparing GSK plc and Insmed Incorporated
SG&A Efficiency Analysis: Comparing Biogen Inc. and Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Insmed Incorporated or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Grifols, S.A.
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Vericel Corporation